| Property | Value |
|---|
|
?:abstract
|
-
Aims There is increasing concern amongst clinicians of a possible increase in venous thromboembolism (VTE) events in patients with COVID-19 There remains limited data defining the incidence of VTE in this population and thus also a paucity of research examining the impact of targeted treatment in patients with thrombotic complications Methods We examined the number of symptomatic VTE events amongst proven COVID-19 patients admitted to a tertiary level academic hospital, over a one-month period Patient characteristics, admission and discharge inflammatory and coagulation markers were included in the analysis Results Sixty-one patients were identified Twelve patients (19 6%) admitted with COVID-19 were treated for a suspected PE Of these patients, 3 patients were discharged on anticoagulation, 3 died and 6 remain inpatients at the end of the study period Discussion COVID-19 patients are at increased risk of VTE This risk may extend beyond the period of admission Further research examining the role of extending the duration of thromboprophylaxis in COVID-19 patients beyond hospital discharge is warranted © 2020, Irish Medical Association All rights reserved
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Pulmonary embolism and covid-19
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}